S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$19.43
+2.3%
$19.83
$16.21
$26.22
$5.17B0.975,995 shs5,252 shs
Masimo Co. stock logo
MASI
Masimo
$134.77
-0.8%
$135.66
$75.22
$198.00
$7.13B0.97576,976 shs352,900 shs
Sonova Holding AG stock logo
SONVY
Sonova
$54.28
+0.1%
$60.78
$45.54
$66.13
$16.18B1.1410,570 shs8,856 shs
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
$177.07
$177.00
$103.67
$177.38
$16.26B1.06746,779 shsN/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
-2.86%-4.52%-5.62%-8.57%-23.75%
Masimo Co. stock logo
MASI
Masimo
-0.51%-4.78%+0.40%+8.74%-30.82%
Sonova Holding AG stock logo
SONVY
Sonova
-0.70%-4.98%-10.73%-14.97%-14.87%
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/AN/AN/AN/AN/AN/AN/AN/A
Masimo Co. stock logo
MASI
Masimo
4.0562 of 5 stars
2.23.00.04.22.61.72.5
Sonova Holding AG stock logo
SONVY
Sonova
1.7995 of 5 stars
0.05.01.70.01.90.01.9
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
1.2365 of 5 stars
0.00.00.04.40.01.72.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
2.33
HoldN/AN/A
Masimo Co. stock logo
MASI
Masimo
2.43
Hold$137.431.97% Upside
Sonova Holding AG stock logo
SONVY
Sonova
1.50
ReduceN/AN/A
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
N/AN/AN/AN/A

Current Analyst Ratings

Latest SONVY, VAR, MASI, and GNGBY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2024
Masimo Co. stock logo
MASI
Masimo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$148.00 ➝ $170.00
3/25/2024
Masimo Co. stock logo
MASI
Masimo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$125.00 ➝ $148.00
3/25/2024
Masimo Co. stock logo
MASI
Masimo
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$145.00 ➝ $166.00
3/25/2024
Masimo Co. stock logo
MASI
Masimo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$117.00 ➝ $160.00
2/26/2024
Masimo Co. stock logo
MASI
Masimo
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$70.00 ➝ $117.00
1/30/2024
Masimo Co. stock logo
MASI
Masimo
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$107.00 ➝ $121.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$3.00B1.76$1.59 per share12.24$10.53 per share1.85
Masimo Co. stock logo
MASI
Masimo
$2.05B3.48$5.69 per share23.70$25.79 per share5.23
Sonova Holding AG stock logo
SONVY
Sonova
$3.92B4.13$3.10 per share17.51$7.64 per share7.10
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
$3.17B5.13$5.07 per share34.94$22.92 per share7.73

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$227.45M$0.8423.13N/A7.58%8.05%4.76%N/A
Masimo Co. stock logo
MASI
Masimo
$81.50M$1.5189.2535.28N/A3.98%13.77%5.98%5/14/2024 (Estimated)
Sonova Holding AG stock logo
SONVY
Sonova
$678.30MN/A0.0020.723.30N/AN/AN/AN/A
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
$269.20M$3.9160.4330.11N/A8.50%18.45%8.08%N/A

Latest SONVY, VAR, MASI, and GNGBY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/27/2024Q4 2023
Masimo Co. stock logo
MASI
Masimo
$0.82$1.25+$0.43$1.87$545.69 million$548.90 million    
2/1/2024Q4 2023
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/A$0.29+$0.29$0.33N/A$930.96 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$0.241.24%N/A28.57%N/A
Masimo Co. stock logo
MASI
Masimo
N/AN/AN/AN/AN/A
Sonova Holding AG stock logo
SONVY
Sonova
$0.611.12%N/AN/AN/A
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
N/AN/AN/AN/AN/A

Latest SONVY, VAR, MASI, and GNGBY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/24/2024
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$0.41644/23/20244/24/20245/14/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/A
0.92
0.56
Masimo Co. stock logo
MASI
Masimo
0.64
2.18
1.22
Sonova Holding AG stock logo
SONVY
Sonova
0.74
1.29
0.90
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
N/A
1.40
1.13

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/A
Masimo Co. stock logo
MASI
Masimo
85.96%
Sonova Holding AG stock logo
SONVY
Sonova
0.01%
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
86.96%

Insider Ownership

CompanyInsider Ownership
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/A
Masimo Co. stock logo
MASI
Masimo
9.70%
Sonova Holding AG stock logo
SONVY
Sonova
0.01%
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
0.78%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
11,739272.37 millionN/ANot Optionable
Masimo Co. stock logo
MASI
Masimo
5,20052.91 million47.78 millionOptionable
Sonova Holding AG stock logo
SONVY
Sonova
17,608298.13 million298.10 millionNot Optionable
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
10,00091.84 millionN/AOptionable

SONVY, VAR, MASI, and GNGBY Headlines

SourceHeadline
DelveInsight Business Research, LLP: Global Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsightDelveInsight Business Research, LLP: Global Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsight
finanznachrichten.de - April 18 at 6:35 PM
This device treats overactive bladder without drugs or surgeryThis device treats overactive bladder without drugs or surgery
medicaldesignandoutsourcing.com - April 18 at 6:35 PM
Global Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsightGlobal Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsight
finance.yahoo.com - April 18 at 6:35 PM
Raigmore Hospital in Scotland selects RayCareRaigmore Hospital in Scotland selects RayCare
finance.yahoo.com - April 17 at 3:14 PM
PH’s 1st dedicated cancer hospital rises in Taguig CityPH’s 1st dedicated cancer hospital rises in Taguig City
msn.com - April 15 at 10:35 PM
Robotic Radiotherapy Market Worth $1.9 billion | MarketsandMarkets™Robotic Radiotherapy Market Worth $1.9 billion | MarketsandMarkets™
finance.yahoo.com - April 15 at 5:35 PM
Robotic Radiotherapy Market Worth $1.9 billion | MarketsandMarketsRobotic Radiotherapy Market Worth $1.9 billion | MarketsandMarkets
finanznachrichten.de - April 15 at 12:34 PM
Ayala cancer hospital ready to serve 10,000 patients this yearAyala cancer hospital ready to serve 10,000 patients this year
msn.com - April 11 at 2:56 PM
Global Superficial Radiation Therapy System Industry is expected to reach US$ 58.2 Million by 2030, With A strong 3.8% CAGR | FMI | FMIGlobal Superficial Radiation Therapy System Industry is expected to reach US$ 58.2 Million by 2030, With A strong 3.8% CAGR | FMI | FMI
fmiblog.com - April 8 at 6:11 PM
Next-generation PARP inhibitor demonstrates clinical benefit in patients with homologous recombination repair-deficient breast cancerNext-generation PARP inhibitor demonstrates clinical benefit in patients with homologous recombination repair-deficient breast cancer
eurekalert.org - April 8 at 1:10 PM
The Lancet: Prostate cancer cases expected to double worldwide between 2020 and 2040, new analysis suggestsThe Lancet: Prostate cancer cases expected to double worldwide between 2020 and 2040, new analysis suggests
eurekalert.org - April 5 at 1:10 AM
Global Brachytherapy Market Set to Skyrocket, Surpassing US$ 2.1 Billion by 2032Global Brachytherapy Market Set to Skyrocket, Surpassing US$ 2.1 Billion by 2032
fmiblog.com - April 4 at 1:43 AM
New method allows miniature robots and surgical instruments to achieve precise localization inside the bodyNew method allows miniature robots and surgical instruments to achieve precise localization inside the body
msn.com - April 2 at 3:39 PM
Global Radiotherapy Device Industry Expects to Reach US$ 12,895.19 Million with 6.6% CAGR by 2033 | FMI studyGlobal Radiotherapy Device Industry Expects to Reach US$ 12,895.19 Million with 6.6% CAGR by 2033 | FMI study
fmiblog.com - April 2 at 3:39 PM
Baxter International lands key FDA clearance for infusion pumpBaxter International lands key FDA clearance for infusion pump
chicagobusiness.com - April 1 at 4:57 PM
Govt Confirms Outbreak of Infectious Disease Amid Covid-19 Fears; Gives Prevention TipsGovt Confirms Outbreak of Infectious Disease Amid Covid-19 Fears; Gives Prevention Tips
msn.com - March 28 at 8:17 PM
Robots in Healthcare Market Future Looks Bright for Market Size with Soaring ProjectionsRobots in Healthcare Market Future Looks Bright for Market Size with Soaring Projections
taiwannews.com.tw - March 28 at 8:44 AM
Radiotherapy Market Will Increase USD 32.6 Billion By 2033 And Has Guessed Around 5.9% CAGRRadiotherapy Market Will Increase USD 32.6 Billion By 2033 And Has Guessed Around 5.9% CAGR
pharmiweb.com - March 25 at 8:52 AM
Kahlert Foundation donates $2.5M to Carroll Hospital for advanced cancer-fighting technologyKahlert Foundation donates $2.5M to Carroll Hospital for advanced cancer-fighting technology
thedailyrecord.com - March 20 at 1:36 PM
Cellino Announces Ed Tekeian as Senior Vice President of EngineeringCellino Announces Ed Tekeian as Senior Vice President of Engineering
finance.yahoo.com - March 18 at 6:19 PM
Global Oncologists Market Report 2024: Precision Medicine and Therapeutic Advancements Drive Expansion to $22.72 Billion by 2028Global Oncologists Market Report 2024: Precision Medicine and Therapeutic Advancements Drive Expansion to $22.72 Billion by 2028
finance.yahoo.com - March 13 at 2:25 PM
Q&A: Chemoradiation With Radiotherapy Improves NSCLC OutcomesQ&A: Chemoradiation With Radiotherapy Improves NSCLC Outcomes
physiciansweekly.com - March 13 at 12:26 AM
Driving becoming increasingly unaffordable in NSW, with regional and low-income communities struggling mostDriving becoming increasingly unaffordable in NSW, with regional and low-income communities struggling most
msn.com - March 11 at 3:07 PM
Forecasted Expansion: Interventional Oncology Ablation Market Expected to Grow at 8.9% CAGRForecasted Expansion: Interventional Oncology Ablation Market Expected to Grow at 8.9% CAGR
pharmiweb.com - March 11 at 3:07 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Getinge AB (publ) logo

Getinge AB (publ)

OTCMKTS:GNGBY
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.
Masimo logo

Masimo

NASDAQ:MASI
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
Sonova logo

Sonova

OTCMKTS:SONVY
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.
Varian Medical Systems logo

Varian Medical Systems

NYSE:VAR
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, artificial intelligence based adaptive radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy afterloaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. The company has a strategic agreement with McKesson Corp. to supply treatment delivery systems and planning, services, and radiotherapy information system solutions to its U.S. Oncology Network and Vantage Oncology affiliated sites of care; and a strategic partnership with Siemens AG to represent Siemens diagnostic imaging products to radiation oncology clinics in the United States and other select markets. Varian Medical Systems, Inc. was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. The company was founded in 1948 and is headquartered in Palo Alto, California.